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In this issue ofCell Metabolism, Ristow and colleagues (Zarse et al., 2012) elucidate a conserved mechanism
through which reduced insulin-IGF1 signaling activates an AMP-kinase-driven metabolic shift toward oxida-
tive proline metabolism. This, in turn, produces an adaptive mitochondrial ROS signal that extends worm life
span. These findings further bolster the concept of mitohormesis as a critical component of conserved aging
and longevity pathways.Historically, reactive oxygen species
(ROS) produced bymitochondrial respira-
tion have been associated with cellular
damage that accelerates aging and
limits life span (Balaban et al., 2005). By
extension, increased stress resistance or
endogenous ROS detoxification systems
are key outcomes of many life span-
extending interventions (Kourtis and
Tavernarakis, 2011). Studies over the
last decade, however, have challenged
the concept of ROS as simply detrimental,
proaging molecules. Under certain condi-
tions, such as during the active phases of
yeast growth or worm (C. elegans) devel-
opment, elevated ROS function as sig-
naling molecules that increase stress
resistance and delay aging at later devel-
opmental stages (Pan et al., 2011; Yang
and Hekimi, 2010). This adaptive re-
sponse to ROS, often called mitochon-
drial hormesis or mitohormesis, has
emerged as a new and important com-
ponent of conserved aging and longevity
pathways (Ristow and Schmeisser,
2011). Indeed, many interventions that
extend life span in model organisms,
such as reduced signaling through the
target of rapamycin (TOR) pathway,
caloric restriction (CR), and exercise, relyat least partially on mitohormesis (Pan
et al., 2011; Schulz et al., 2007; Yang
and Hekimi, 2010). We may now also
add insulin/IGF1 signaling (IIS) to this list,
as work by Zarse et al. in this issue iden-
tifies a key role for AMPK-regulated
oxidative proline catabolism in initiating
adaptive mitochondrial ROS signaling,
which extends life span under conditions
of reduced IIS (Zarse et al., 2012).
In model organisms, reduced IIS
extends life span in part via increasing
stress resistance and altering metabolism
(Baumeister et al., 2006). Using both
worm and mouse cell culture models,
Zarse et al. (2012) confirmed that consti-
tutively impaired IIS increases mitochon-
drial respiration but decreases ROS
levels. This seemingly paradoxical finding
could be explained if reducing IIS also
induces ROS detoxification pathways.
Accordingly, RNAi against the insulin-like
receptor DAF-2 in C. elegans revealed
that ROS production increases during
the acute response to reduced IIS, and
elevated antioxidant defenses (e.g., SOD
and catalase) account for the decrease
in total ROS levels observed later. Entirely
consistent with increased ROS func-
tioning as signaling molecules to initiatea mitohormetic response, treatment with
antioxidants during early time points
diminishes the ability of reduced IIS to
extend nematode life span. Furthermore,
the adaptive ROS signal acts through
the worm homologs of p38 (PMK-1) and
NRF-2 (SKN-1) to ultimately induce SOD
and catalase gene expression, promoting
stress resistance during aging.
Insulin signaling tightly regulates glu-
cose metabolism to maintain cell function
in the presence of fluctuating nutrient
availability. To address the mechanism
by which reduced IIS induces ROS
production, Zarse and colleagues (Zarse
et al., 2012) used RNA-seq in worm and
mouse models of reduced IIS. This
approach revealed a shift in metabolism
that includes AMPK-dependent induction
of genes required for mitochondrial pro-
line catabolism. Supporting the impor-
tance of proline in life span extension,
RNAi knockdown of the implicated pro-
line oxidase/dehydrogenase abrogates
some of the life span-extending effects
of reduced IIS. Furthermore, proline sup-
plementation alone extended worm life
span. This led Zarse et al. to conclude that
proline catabolism provides substrates to
support mitochondrial respiration (i.e.,15, April 4, 2012 ª2012 Elsevier Inc. 417
Figure 1. Proposed Model for Mitohormesis in Response to Reduced Insulin/IGF1 Signaling
(A) In C. elegans and mice (MEFs), impaired insulin/IGF1 signaling reduces glucose uptake, ultimately
increasing the cellular AMP/ATP ratio. This energy-stress signal activates AMP kinase, which engages
a transcriptional ‘‘metabolic shift program’’ that includes induction of mitochondrial proline oxidase.
This shift in metabolism generates mitochondrial ROS that initiate an adaptive ROS signaling pathway.
(B) The adaptive mitochondrial ROS signal, through PMK-1 (p38) and SKN-1 (NRF2), activates a protective
transcriptional ‘‘stress response program.’’ This involves increased expression of SOD and catalase
(CAT), which detoxify ROS and improve cellular stress resistance to ultimately help extend C. elegans
life span.
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Previewsglutamate and a-ketoglutarate), gener-
ating conditions that produce signaling
ROS (Figure 1). Their findings are consis-
tent with previous work in mammalian
cells showing that increased proline
oxidase activity promotes ROS produc-
tion that can be either beneficial or delete-
rious (e.g., promote apoptosis), depend-
ing on the precise biological context
(Phang and Liu, 2012). Similarly, the ability
of AMPK to induce ROS in this study
contrasts with others in which AMPK
appears to sense ROS, sometimes with
deleterious consequences (Raimundo
et al., 2012). Clearly, communication
between AMPK and ROS is bidirectional
and must be fine-tuned under specific
conditions and in various tissues to
ensure that the appropriate outcome is
achieved. Given the degree of mecha-
nistic overlap between CR- and IIS-
mediated life span extension, it will be
particularly interesting to determine if
proline catabolism, AMPK-ROS signaling,
and/or mitohormesis also contributes to
longevity and health span under CR and
in other conserved aging pathways.
ROS signaling and mitohormesis
clearly have important emerging roles in
regulating stress resistance and life418 Cell Metabolism 15, April 4, 2012 ª2012span. The number of diverse situations
and contexts capable of activating ROS
signaling functions suggests that mecha-
nisms of signaling may be equally diverse.
For example, different species of ROS
(e.g., superoxide and hydrogen peroxide),
or those produced in different cellular
compartments, may activate unique sig-
naling pathways and elicit distinct out-
comes. Ristow and colleagues, and
others (Pan et al., 2011; Raimundo et al.,
2012; Yang and Hekimi, 2010), show
that mitochondrial superoxide per se can
function as a signaling ROS, despite its
poor diffusion and lack of an obvious
mechanism of signal transduction. Thus,
going forward it will be important to
describe the specific biochemical mecha-
nisms by which mitochondrial superoxide
and other ROS activate sensor proteins
and relay retrograde signals to the
cytoplasm and nucleus. It is also worth
emphasizing that, although transcrip-
tional regulation of antioxidant genes is
one important outcome of ROS signaling
and adaption, many other cellular pro-
cesses may also be affected. Full under-
standing of the outcomes of ROS sig-
naling will likely require genome-wide
transcriptional or proteomic studies toElsevier Inc.identify additional cellular functions that
may contribute to increased stress resis-
tance and life span extension following
ROS signaling. Finally, it will be interesting
to investigate what other mitochondrial
outputs, in addition to ROS, induce
mitohormesis. Given the contribution of
mitochondria to numerous cellular pro-
cesses, different types of mitochondrial
stress likely activate specific signal-
ing pathways and unique adaptive re-
sponses, with the mitochondrial unfolded
protein response being a salient case in
point. With a firm appreciation for the
importance of mitochondrial stress sig-
naling in regulating life span, future
studies on the precise signaling mecha-
nisms involved will continue to challenge
the precarious concept of singular, proag-
ing effects of mitochondrial dysfunction
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